These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17696793)

  • 1. The economics of temozolomide in brain cancer.
    Crott R
    Expert Opin Pharmacother; 2007 Aug; 8(12):1923-9. PubMed ID: 17696793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
    Dinnes J; Cave C; Huang S; Major K; Milne R
    Health Technol Assess; 2001; 5(13):1-73. PubMed ID: 11359682
    [No Abstract]   [Full Text] [Related]  

  • 3. Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia.
    Mabasa VH; Taylor SC
    J Oncol Pharm Pract; 2006 Jun; 12(2):105-11. PubMed ID: 16984749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
    Wasserfallen JB; Ostermann S; Leyvraz S; Stupp R
    Neuro Oncol; 2005 Apr; 7(2):189-95. PubMed ID: 15831237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.
    Lamers LM; Stupp R; van den Bent MJ; Al MJ; Gorlia T; Wasserfallen JB; Mittmann N; Jin Seung S; Crott R; Uyl-de Groot CA;
    Cancer; 2008 Mar; 112(6):1337-44. PubMed ID: 18213621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme.
    Uyl-de Groot CA; Stupp R; van der Bent M
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):235-41. PubMed ID: 19527095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy in high-grade gliomas.
    Ulutin C
    Tumori; 2007; 93(5):526; author reply 526. PubMed ID: 18038893
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits of adjuvant chemotherapy in high-grade gliomas.
    DeAngelis LM
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):15-8. PubMed ID: 14765379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide treatment in glioma--experiences in two university hospitals in Finland.
    Mäenpää HO; Aaltonen K; Mäntylä R; Minn H
    Acta Oncol; 2004; 43(6):579-84. PubMed ID: 15370616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma.
    Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
    Schiff D
    Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
    Broniscer A; Chintagumpala M; Fouladi M; Krasin MJ; Kocak M; Bowers DC; Iacono LC; Merchant TE; Stewart CF; Houghton PJ; Kun LE; Ledet D; Gajjar A
    J Neurooncol; 2006 Feb; 76(3):313-9. PubMed ID: 16200343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
    Wang L; Tu Q; Zhou W; Zhou R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of temozolomide in recurrent malignant gliomas.
    Gaya A; Rees J; Greenstein A; Stebbing J
    Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide for pediatric high-grade gliomas.
    Packer RJ
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):111-3. PubMed ID: 22249491
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
    Parlato C; Barbarisi M; Moraci M; Moraci A
    Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.